These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Current concepts in the treatment of cardiac arrhythmias. Manz M; Wagner WL; Grube E; Lüderitz B J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S124-30. PubMed ID: 2423785 [TBL] [Abstract][Full Text] [Related]
27. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man. Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022 [TBL] [Abstract][Full Text] [Related]
28. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure. De Kock MR; Detry JM J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782 [TBL] [Abstract][Full Text] [Related]
29. Antiarrhythmic and electrophysiological effects of alpha adrenoceptor blockade during myocardial ischaemia and reperfusion in isolated guinea-pig heart. Penny WJ; Culling W; Lewis MJ; Sheridan DJ J Mol Cell Cardiol; 1985 Apr; 17(4):399-409. PubMed ID: 2862287 [TBL] [Abstract][Full Text] [Related]
30. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs. Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154 [TBL] [Abstract][Full Text] [Related]
31. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise. Bache RJ; Homans DC; Schwartz JS; Dai XZ J Pharmacol Exp Ther; 1988 Apr; 245(1):232-7. PubMed ID: 2896237 [TBL] [Abstract][Full Text] [Related]
32. The effects of indoramin on histamine and antigen-induced changes in respiration in guinea-pigs. Hamer C; Temple DM Agents Actions; 1980 Nov; 10(5):399-402. PubMed ID: 7211574 [TBL] [Abstract][Full Text] [Related]
33. Antihypertensive effects of indoramin and prazosin in combination with hydrochlorothiazide. Solomon R J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S56-62. PubMed ID: 2423799 [TBL] [Abstract][Full Text] [Related]
34. Magnesium abolishes inadequate kinetics of frequency adaptation of the Q-aT interval in the presence of sotalol. Stark G; Schwarzl I; Heiden U; Stark U; Tritthart HA Cardiovasc Res; 1997 Jul; 35(1):43-51. PubMed ID: 9302346 [TBL] [Abstract][Full Text] [Related]
36. The in-vivo cardiovascular effects of a putative class III anti-arrhythmic drug, AM 92016. Hagerty MJ; Wainwright CL; Kane KA J Pharm Pharmacol; 1996 Apr; 48(4):417-21. PubMed ID: 8794994 [TBL] [Abstract][Full Text] [Related]
37. The cardiovascular effects of centrally and peripherally administered indoramin in conscious rats. Porter JP; Bonham AC; Mangiapane ML; Webb RL; Brody MJ Eur J Pharmacol; 1985 Feb; 109(1):9-17. PubMed ID: 3996469 [TBL] [Abstract][Full Text] [Related]
38. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients. Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732 [TBL] [Abstract][Full Text] [Related]
39. Effect of indoramin on finger blood flow in vasospastic patients. Clement DL Eur J Clin Pharmacol; 1978 Dec; 14(5):331-3. PubMed ID: 729626 [TBL] [Abstract][Full Text] [Related]
40. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog. Leboeuf J; Basiez M; Massingham R Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]